Cargando…
Immunotherapy of Genitourinary Malignancies
Most cancer patients are treated with some combination of surgery, radiation, and chemotherapy. Despite recent advances in local therapy with curative intent, chemotherapeutic treatments for metastatic disease often remain unsatisfying due to severe side effects and incomplete long-term remission. T...
Autores principales: | Inamoto, Teruo, Azuma, Haruhito |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3317259/ https://www.ncbi.nlm.nih.gov/pubmed/22481927 http://dx.doi.org/10.1155/2012/397267 |
Ejemplares similares
-
Immunotherapy in genitourinary malignancies
por: Mehta, Kathan, et al.
Publicado: (2017) -
Editorial Comment to Case of renal mucinous tubular and spindle cell carcinoma with high nuclear grade
por: Inamoto, Teruo, et al.
Publicado: (2019) -
Editorial Comment to Prostate carcinoma with neuroendocrine differentiation successfully treated by early detection with imaging examination
por: Inamoto, Teruo, et al.
Publicado: (2020) -
CRISPR Screen Contributes to Novel Target Discovery in Prostate Cancer
por: Tsujino, Takuya, et al.
Publicado: (2021) -
The promise of immunotherapy in genitourinary malignancies
por: Zhang, Tian, et al.
Publicado: (2018)